Pharmacokinetics of cisatracurium in children of different ages
Yihui Li, Mao Ye, XU Bin-bing, Lin Bai, Ying Xu
Abstract
Yihui Li, Mao Ye, XU Bin-bing, Lin Bai, Ying Xu
Abstract
Objective To study the pharmacokinetics of cisatracurium in children of different ages.Methods Twenty-four ASA Ⅰ or Ⅱ children undergoing elective surgery were divided into 2 age groups:group A <2 yr and group B ≥2 yr - < 5 yr.Arterial blood samples were obtained at 2,4,6,8,10,15,20,30,45,60,90,120 min after a bolus dose of cisatracurium (0.15 mg/kg).Plasma concentrations (Cp) of cisatracurium were measured by high performance liquid chromatography.The data obtained were analyzed by 3P97 pharmacokinetic software.Distribution half-life( t1/2α ),elimination half life( t1/2β ),A,B,distribution rate constant ( α ),elimination rate constant (/β),central volume of distribution (Vc),total clearance (CL) and apparent volume of distribution (Vd),K1o,K12,K21 were recorded.Results The Cp versus time curve for cisatracurium was fitted to a two compartment pharmacokinetic model.There were no significant differences in t1/2α,t1/2β,A,B,a,β,K10,K12,K21 between the 2 groups.Group A had a significantly larger Vc,CL and Vd than group B.Conclusion The Cp versus time curve for cisatracurium is best described by a two-compartment pharmacokinetic model.Vc,CL and Vd are significantly larger in children under the age of 2- than in children between 2 and 5. Key words: Neuromuscular nondepolarizing agents; Child; Pharmacokinetics
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the pharmacokinetics of cisatracurium in children of different ages.Methods Twenty-four ASA Ⅰ or Ⅱ children undergoing elective surgery were divided into 2 age groups:group A <2 yr and group B ≥2 yr - < 5 yr.Arterial blood samples were obtained at 2,4,6,8,10,15,20,30,45,60,90,120 min after a bolus dose of cisatracurium (0.15 mg/kg).Plasma concentrations (Cp) of cisatracurium were measured by high performance liquid chromatography.The data obtained were analyzed by 3P97 pharmacokinetic software.Distribution half-life( t1/2α ),elimination half life( t1/2β ),A,B,distribution rate constant ( α ),elimination rate constant (/β),central volume of distribution (Vc),total clearance (CL) and apparent volume of distribution (Vd),K1o,K12,K21 were recorded.Results The Cp versus time curve for cisatracurium was fitted to a two compartment pharmacokinetic model.There were no significant differences in t1/2α,t1/2β,A,B,a,β,K10,K12,K21 between the 2 groups.Group A had a significantly larger Vc,CL and Vd than group B.Conclusion The Cp versus time curve for cisatracurium is best described by a two-compartment pharmacokinetic model.Vc,CL and Vd are significantly larger in children under the age of 2- than in children between 2 and 5. Key words: Neuromuscular nondepolarizing agents; Child; Pharmacokinetics
Key concepts: Pharmacokinetics, Intravenous bolus, Volume of distribution, Elimination rate constant, Anesthesia, Distribution (mathematics), Bolus (digestion), Half-life